TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global COVID-19 Molecular Diagnostics Market Size, Status and Forecast 2022-2028

Global COVID-19 Molecular Diagnostics Market Size, Status and Forecast 2022-2028

  • Category:ICT & Media
  • Published on : 04 September 2022
  • Pages :107
  • Formats:
  • Report Code:SMR-7322364
OfferClick for best price

Best Price: $3120

COVID19 Molecular Diagnostics Market Size, Share 2022


Market Analysis and Insights: Global COVID19 Molecular Diagnostics Market

The global COVID19 Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global COVID19 Molecular Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global COVID19 Molecular Diagnostics market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global COVID19 Molecular Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global COVID19 Molecular Diagnostics market.

Global COVID19 Molecular Diagnostics Scope and Market Size

This report focuses on the global COVID-19 Molecular Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the COVID-19 Molecular Diagnostics development in North America, Europe, China and Japan, etc.

Segment by Type

High-throughput Sequencing

Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR

Immunological Detection

Segment by Application

Hospitals

Scientific Research

Biodiagnostics

By Region

North America

Europe

China

Japan

By Company

Cellex

Abbott

Roche

BioMedomics

BD

Henry Schein

Safecare Bio-Tech

Thermo Fisher

Bio-rad

Agilent

Ortho Clinical Diagnostics

Zhejiang Orient Gene Biotech

Innovita Biological Technology

Guangzhou Wondfo Biotech

Guangdong Hecin-Scientific

Dynamiker Biotechnology (Tianjin)

ADVAITE

Mayo Clinic Laboratories

Chembio Diagnostics

Mount Sinai Laboratory

QIAGEN

Bioer

Biosynex

Esco

Analytik Jena

Techne

Da An Gene

BGI

Shanghai ZJ Bio-Tech

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes COVID19 Molecular Diagnostics product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of COVID19 Molecular Diagnostics, with price, sales, revenue, and global market share of COVID19 Molecular Diagnostics from 2019 to 2022.

Chapter 3, the COVID19 Molecular Diagnostics competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the COVID19 Molecular Diagnostics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the COVID19 Molecular Diagnostics market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of COVID19 Molecular Diagnostics.

Chapter 13, 14, and 15, to describe COVID19 Molecular Diagnostics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 COVID19 Molecular Diagnostics Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global COVID-19 Molecular Diagnostics Market Size, Status and Forecast 2022-2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 107 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COVID-19 Molecular Diagnostics Market Size Growth Rate by Type (2022-2028)
1.2.2 High-throughput Sequencing
1.2.3 Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
1.2.4 Immunological Detection
1.3 Market by Application
1.3.1 Global COVID-19 Molecular Diagnostics Market Share by Application (2022-2028)
1.3.2 Hospitals
1.3.3 Scientific Research
1.3.4 Biodiagnostics
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global COVID-19 Molecular Diagnostics Market Size
2.2 COVID-19 Molecular Diagnostics Market Size by Regions
2.2.1 COVID-19 Molecular Diagnostics Growth Rate by Regions (2022-2028)
2.2.2 COVID-19 Molecular Diagnostics Market Share by Regions (2022-2028)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 COVID-19 Molecular Diagnostics Revenue by Players (2022 & 2028)
3.2 COVID-19 Molecular Diagnostics Key Players Headquarters and Area Served
3.3 Key Players COVID-19 Molecular Diagnostics Product/Solution/Service
3.4 Date of Enter into COVID-19 Molecular Diagnostics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and by Application
4.1 Global COVID-19 Molecular Diagnostics Market Size by Type (2022-2028)
4.2 Global COVID-19 Molecular Diagnostics Market Size by Application (2022-2028)
5 North America
5.1 North America COVID-19 Molecular Diagnostics Market Forecast (2022-2028)
5.2 COVID-19 Molecular Diagnostics Key Players in North America
5.3 North America COVID-19 Molecular Diagnostics Market Size by Type
5.4 North America COVID-19 Molecular Diagnostics Market Size by Application
6 Europe
6.1 Europe COVID-19 Molecular Diagnostics Market Forecast (2022-2028)
6.2 COVID-19 Molecular Diagnostics Key Players in Europe
6.3 Europe COVID-19 Molecular Diagnostics Market Size by Type
6.4 Europe COVID-19 Molecular Diagnostics Market Size by Application
7 Asia-Pacific
7.1 Asia-Pacific COVID-19 Molecular Diagnostics Market Forecast (2022-2028)
7.2 COVID-19 Molecular Diagnostics Key Players in Asia-Pacific
7.3 Asia-Pacific COVID-19 Molecular Diagnostics Market Size by Type
7.4 Asia-Pacific COVID-19 Molecular Diagnostics Market Size by Application
8 Rest of World
8.1 Latin America
8.1.1 Latin America COVID-19 Molecular Diagnostics Market Analysis
8.1.2 Key Players in Latin America
8.2 Middle East & Africa
8.2.1 Middle East & Africa COVID-19 Molecular Diagnostics Market Analysis
8.2.2 Key Players in Middle East & Africa
9 International Player Profiles
9.1 Cellex
9.1.1 Cellex Company Details
9.1.2 Cellex Description and Business Overview
9.1.3 Cellex COVID-19 Molecular Diagnostics Introduction
9.1.4 Cellex Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.1.5 Cellex Recent Development
9.2 Abbott
9.2.1 Abbott Company Details
9.2.2 Abbott Description and Business Overview
9.2.3 Abbott COVID-19 Molecular Diagnostics Introduction
9.2.4 Abbott Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.2.5 Abbott Recent Development
9.3 Roche
9.3.1 Roche Company Details
9.3.2 Roche Description and Business Overview
9.3.3 Roche COVID-19 Molecular Diagnostics Introduction
9.3.4 Roche Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.3.5 Roche Recent Development
9.4 BioMedomics
9.4.1 BioMedomics Company Details
9.4.2 BioMedomics Description and Business Overview
9.4.3 BioMedomics COVID-19 Molecular Diagnostics Introduction
9.4.4 BioMedomics Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.4.5 BioMedomics Recent Development
9.5 BD
9.5.1 BD Company Details
9.5.2 BD Description and Business Overview
9.5.3 BD COVID-19 Molecular Diagnostics Introduction
9.5.4 BD Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.5.5 BD Recent Development
9.6 Henry Schein
9.6.1 Henry Schein Company Details
9.6.2 Henry Schein Description and Business Overview
9.6.3 Henry Schein COVID-19 Molecular Diagnostics Introduction
9.6.4 Henry Schein Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.6.5 Henry Schein Recent Development
9.7 Safecare Bio-Tech
9.7.1 Safecare Bio-Tech Company Details
9.7.2 Safecare Bio-Tech Description and Business Overview
9.7.3 Safecare Bio-Tech COVID-19 Molecular Diagnostics Introduction
9.7.4 Safecare Bio-Tech Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.7.5 Safecare Bio-Tech Recent Development
9.8 Thermo Fisher
9.8.1 Thermo Fisher Company Details
9.8.2 Thermo Fisher Description and Business Overview
9.8.3 Thermo Fisher COVID-19 Molecular Diagnostics Introduction
9.8.4 Thermo Fisher Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.8.5 Thermo Fisher Recent Development
9.9 Bio-rad
9.9.1 Bio-rad Company Details
9.9.2 Bio-rad Description and Business Overview
9.9.3 Bio-rad COVID-19 Molecular Diagnostics Introduction
9.9.4 Bio-rad Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.9.5 Bio-rad Recent Development
9.10 Agilent
9.10.1 Agilent Company Details
9.10.2 Agilent Description and Business Overview
9.10.3 Agilent COVID-19 Molecular Diagnostics Introduction
9.10.4 Agilent Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.10.5 Agilent Recent Development
9.11 Ortho Clinical Diagnostics
9.11.1 Ortho Clinical Diagnostics Company Details
9.11.2 Ortho Clinical Diagnostics Description and Business Overview
9.11.3 Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Introduction
9.11.4 Ortho Clinical Diagnostics Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.11.5 Ortho Clinical Diagnostics Recent Development
9.12 Zhejiang Orient Gene Biotech
9.12.1 Zhejiang Orient Gene Biotech Company Details
9.12.2 Zhejiang Orient Gene Biotech Description and Business Overview
9.12.3 Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Introduction
9.12.4 Zhejiang Orient Gene Biotech Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.12.5 Zhejiang Orient Gene Biotech Recent Development
9.13 Innovita Biological Technology
9.13.1 Innovita Biological Technology Company Details
9.13.2 Innovita Biological Technology Description and Business Overview
9.13.3 Innovita Biological Technology COVID-19 Molecular Diagnostics Introduction
9.13.4 Innovita Biological Technology Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.13.5 Innovita Biological Technology Recent Development
9.14 Guangzhou Wondfo Biotech
9.14.1 Guangzhou Wondfo Biotech Company Details
9.14.2 Guangzhou Wondfo Biotech Description and Business Overview
9.14.3 Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Introduction
9.14.4 Guangzhou Wondfo Biotech Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.14.5 Guangzhou Wondfo Biotech Recent Development
9.15 Guangdong Hecin-Scientific
9.15.1 Guangdong Hecin-Scientific Company Details
9.15.2 Guangdong Hecin-Scientific Description and Business Overview
9.15.3 Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Introduction
9.15.4 Guangdong Hecin-Scientific Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.15.5 Guangdong Hecin-Scientific Recent Development
9.16 Dynamiker Biotechnology (Tianjin)
9.16.1 Company Details
9.16.2 Dynamiker Biotechnology (Tianjin) Description and Business Overview
9.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Introduction
9.16.4 Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.16.5 Dynamiker Biotechnology (Tianjin) Recent Development
9.17 ADVAITE
9.17.1 ADVAITE Company Details
9.17.2 ADVAITE Description and Business Overview
9.17.3 ADVAITE COVID-19 Molecular Diagnostics Introduction
9.17.4 ADVAITE Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.17.5 ADVAITE Recent Development
9.18 Mayo Clinic Laboratories
9.18.1 Mayo Clinic Laboratories Company Details
9.18.2 Mayo Clinic Laboratories Description and Business Overview
9.18.3 Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Introduction
9.18.4 Mayo Clinic Laboratories Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.18.5 Mayo Clinic Laboratories Recent Development
9.19 Chembio Diagnostics
9.19.1 Chembio Diagnostics Company Details
9.19.2 Chembio Diagnostics Description and Business Overview
9.19.3 Chembio Diagnostics COVID-19 Molecular Diagnostics Introduction
9.19.4 Chembio Diagnostics Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.19.5 Chembio Diagnostics Recent Development
9.20 Mount Sinai Laboratory
9.20.1 Mount Sinai Laboratory Company Details
9.20.2 Mount Sinai Laboratory Description and Business Overview
9.20.3 Mount Sinai Laboratory COVID-19 Molecular Diagnostics Introduction
9.20.4 Mount Sinai Laboratory Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.20.5 Mount Sinai Laboratory Recent Development
9.21 QIAGEN
9.21.1 QIAGEN Company Details
9.21.2 QIAGEN Description and Business Overview
9.21.3 QIAGEN COVID-19 Molecular Diagnostics Introduction
9.21.4 QIAGEN Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.21.5 QIAGEN Recent Development
9.22 Bioer
9.22.1 Bioer Company Details
9.22.2 Bioer Description and Business Overview
9.22.3 Bioer COVID-19 Molecular Diagnostics Introduction
9.22.4 Bioer Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.22.5 Bioer Recent Development
9.23 Biosynex
9.23.1 Biosynex Company Details
9.23.2 Biosynex Description and Business Overview
9.23.3 Biosynex COVID-19 Molecular Diagnostics Introduction
9.23.4 Biosynex Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.23.5 Biosynex Recent Development
9.24 Esco
9.24.1 Esco Company Details
9.24.2 Esco Description and Business Overview
9.24.3 Esco COVID-19 Molecular Diagnostics Introduction
9.24.4 Esco Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.24.5 Esco Recent Development
9.25 Analytik Jena
9.25.1 Analytik Jena Company Details
9.25.2 Analytik Jena Description and Business Overview
9.25.3 Analytik Jena COVID-19 Molecular Diagnostics Introduction
9.25.4 Analytik Jena Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.25.5 Analytik Jena Recent Development
9.26 Techne
9.26.1 Techne Company Details
9.26.2 Techne Description and Business Overview
9.26.3 Techne COVID-19 Molecular Diagnostics Introduction
9.26.4 Techne Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.26.5 Techne Recent Development
9.27 Da An Gene
9.27.1 Da An Gene Company Details
9.27.2 Da An Gene Description and Business Overview
9.27.3 Da An Gene COVID-19 Molecular Diagnostics Introduction
9.27.4 Da An Gene Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.27.5 Da An Gene Recent Development
9.28 BGI
9.28.1 BGI Company Details
9.28.2 BGI Description and Business Overview
9.28.3 BGI COVID-19 Molecular Diagnostics Introduction
9.28.4 BGI Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.28.5 BGI Recent Development
9.29 Shanghai ZJ Bio-Tech
9.29.1 Shanghai ZJ Bio-Tech Company Details
9.29.2 Shanghai ZJ Bio-Tech Description and Business Overview
9.29.3 Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Introduction
9.29.4 Shanghai ZJ Bio-Tech Revenue in COVID-19 Molecular Diagnostics Business (2022 & 2028)
9.29.5 Shanghai ZJ Bio-Tech Recent Development
10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global COVID-19 Molecular Diagnostics Market Size Growth Rate by Type (2022-2028) (US$ Million)
Table 2. Key Players of High-throughput Sequencing
Table 3. Key Players of Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
Table 4. Key Players of Immunological Detection
Table 5. Global COVID-19 Molecular Diagnostics Market Size Growth by Application (2022-2028) (US$ Million)
Table 6. Global COVID-19 Molecular Diagnostics Market Size by Regions (2022-2028) (US$ Million)
Table 7. Global COVID-19 Molecular Diagnostics Market Share by Regions (2022-2028)
Table 8. Market Top Trends
Table 9. Market Use Cases
Table 10. Global COVID-19 Molecular Diagnostics Revenue by Players (2022 & 2028) (US$ Million)
Table 11. Global COVID-19 Molecular Diagnostics Market Share by Players (2022 &2028)
Table 12. Key Players Headquarters and Area Served
Table 13. Key Players COVID-19 Molecular Diagnostics Product/Solution/Service
Table 14. Date of Enter into COVID-19 Molecular Diagnostics Market
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global COVID-19 Molecular Diagnostics Market Size by Type (2022-2028) (US$ Million)
Table 17. Global COVID-19 Molecular Diagnostics Market Size Share by Type (2022-2028)
Table 18. Global COVID-19 Molecular Diagnostics Market Size by Application (2022-2028) (US$ Million)
Table 19. Global COVID-19 Molecular Diagnostics Market Size Share by Application (2022-2028)
Table 20. North America Key Players COVID-19 Molecular Diagnostics Revenue (2022 & 2028) & (US$ Million)
Table 21. North America Key Players COVID-19 Molecular Diagnostics Market Share (2022 & 2028)
Table 22. North America COVID-19 Molecular Diagnostics Market Size by Type (2022-2028) (US$ Million)
Table 23. North America COVID-19 Molecular Diagnostics Market Share by Type (2022-2028)
Table 24. North America COVID-19 Molecular Diagnostics Market Size by Application (2022-2028) (US$ Million)
Table 25. North America COVID-19 Molecular Diagnostics Market Share by Application (2022-2028)
Table 26. Europe Key Players COVID-19 Molecular Diagnostics Revenue (2022 & 2028) & (US$ Million)
Table 27. Europe Key Players COVID-19 Molecular Diagnostics Market Share (2022 & 2028)
Table 28. Europe COVID-19 Molecular Diagnostics Market Size by Type (2022-2028) (US$ Million)
Table 29. Europe COVID-19 Molecular Diagnostics Market Share by Type (2022-2028)
Table 30. Europe COVID-19 Molecular Diagnostics Market Size by Application (2022-2028) (US$ Million)
Table 31. Europe COVID-19 Molecular Diagnostics Market Share by Application (2022-2028)
Table 32. Asia-Pacific Key Players COVID-19 Molecular Diagnostics Revenue (2022 & 2028) & (US$ Million)
Table 33. Asia-Pacific Key Players COVID-19 Molecular Diagnostics Market Share (2022 & 2028)
Table 34. Asia-Pacific COVID-19 Molecular Diagnostics Market Size by Type (2022-2028) (US$ Million)
Table 35. Asia-Pacific COVID-19 Molecular Diagnostics Market Share by Type (2022-2028)
Table 36. Asia-Pacific COVID-19 Molecular Diagnostics Market Size by Application (2022-2028) (US$ Million)
Table 37. Asia-Pacific COVID-19 Molecular Diagnostics Market Share by Application (2022-2028)
Table 38. Key Players in Latin America
Table 39. Key Players in Middle East & Africa
Table 40. Cellex Company Details
Table 41. Cellex Description and Business Overview
Table 42. Cellex COVID-19 Molecular Diagnostics Product
Table 43. Cellex Revenue in COVID-19 Molecular Diagnostics Business 2022 & 2028
Table 44. Cellex Recent Development
Table 45. Abbott Company Details
Table 46. Abbott Description and Business Overview
Table 47. Abbott COVID-19 Molecular Diagnostics Product
Table 48. Abbott Revenue in COVID-19 Molecular Diagnostics Business 2022 & 2028
Table 49. Abbott Recent Development
Table 50. Roche Company Details
Table 51. Roche Description and Business Overview
Table 52. Roche COVID-19 Molecular Diagnostics Product
Table 53. Roche Revenue in COVID-19 Molecular Diagnostics Business 2022 & 2028
Table 54. Roche Recent Development
Table 55. BioMedomics Company Details
Table 56. BioMedomics Description and Business Overview
Table 57. BioMedomics COVID-19 Molecular Diagnostics Product
Table 58. BioMedomics Revenue in COVID-19 Molecular Diagnostics Business 2022 & 2028
Table 59. BioMedomics Recent Development
Table 60. BD Company Details
Table 61. BD Description and Business Overview
Table 62. BD COVID-19 Molecular Diagnostics Product
Table 63. BD Revenue in COVID-19 Molecular Diagnostics Business 2022 & 2028
Table 64. BD Recent Development
Table 65. Henry Schein Company Details
Table 66. Henry Schein Description and Business Overview
Table 67. Henry Schein COVID-19 Molecular Diagnostics Product
Table 68. Henry Schein Revenue in COVID-19 Molecular Diagnostics Business 2022 & 2028
Table 69. Henry Schein Recent Development
Table 70. Safecare Bio-Tech Company Details
Table 71. Safecare Bio-Tech Description and Business Overview
Table 72. Safecare Bio-Tech COVID-19 Molecular Diagnostics Product
Table 73. Safecare Bio-Tech Revenue in COVID-19 Molecular Diagnostics Business 2022 & 2028
Table 74. Safecare Bio-Tech Recent Development
Table 75. Thermo Fisher Company Details
Table 76. Thermo Fisher Description and Business Overview
Table 77. Thermo Fisher COVID-19 Molecular Diagnostics Product
Table 78. Thermo Fisher Revenue in COVID-19 Molecular Diagnostics Business 2022 & 2028
Table 79. Thermo Fisher Recent Development
Table 80. Bio-rad Company Details
Table 81. Bio-rad Description and Business Overview
Table 82. Bio-rad COVID-19 Molecular Diagnostics Product
Table 83. Bio-rad Revenue in COVID-19 Molecular Diagnostics Business 2022 & 2028
Table 84. Bio-rad Recent Development
Table 85. Agilent Company Details
Table 86. Agilent Description and Business Overview
Table 87. Agilent COVID-19 Molecular Diagnostics Product
Table 88. Agilent Revenue in COVID-19 Molecular Diagnostics Business 2022 & 2028
Table 89. Agilent Recent Development
Table 90. Ortho Clinical Diagnostics Company Details
Table 91. Ortho Clinical Diagnostics Description and Business Overview
Table 92. Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Product
Table 93. Ortho Clinical Diagnostics Revenue in COVID-19 Molecular Diagnostics Business 2022 & 2028
Table 94. Ortho Clinical Diagnostics Recent Development
Table 95. Zhejiang Orient Gene Biotech Company Details
Table 96. Zhejiang Orient Gene Biotech Description and Business Overview
Table 97. Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Product
Table 98. Zhejiang Orient Gene Biotech Revenue in COVID-19 Molecular Diagnostics Business 2022 & 2028
Table 99. Zhejiang Orient Gene Biotech Recent Development
Table 100. Innovita Biological Technology Company Details
Table 101. Innovita Biological Technology Description and Business Overview
Table 102. Innovita Biological Technology COVID-19 Molecular Diagnostics Product
Table 103. Innovita Biological Technology Revenue in COVID-19 Molecular Diagnostics Business 2022 & 2028
Table 104. Innovita Biological Technology Recent Development
Table 105. Guangzhou Wondfo Biotech Company Details
Table 106. Guangzhou Wondfo Biotech Description and Business Overview
Table 107. Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Product
Table 108. Guangzhou Wondfo Biotech Revenue in COVID-19 Molecular Diagnostics Business 2022 & 2028
Table 109. Guangzhou Wondfo Biotech Recent Development
Table 110. Guangdong Hecin-Scientific Company Details
Table 111. Guangdong Hecin-Scientific Description and Business Overview
Table 112. Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Product
Table 113. Guangdong Hecin-Scientific Revenue in COVID-19 Molecular Diagnostics Business 2022 & 2028
Table 114. Guangdong Hecin-Scientific Recent Development
Table 115. Dynamiker Biotechnology (Tianjin) Company Details
Table 116. Dynamiker Biotechnology (Tianjin) Description and Business Overview
Table 117. Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Product
Table 118. Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 Molecular Diagnostics Business 2022 & 2028
Table 119. Dynamiker Biotechnology (Tianjin) Recent Development
Table 120. ADVAITE Company Details
Table 121. ADVAITE Description and Business Overview
Table 122. ADVAITE COVID-19 Molecular Diagnostics Product
Table 123. ADVAITE Revenue in COVID-19 Molecular Diagnostics Business 2022 & 2028
Table 124. ADVAITE Recent Development
Table 125. Mayo Clinic Laboratories Company Details
Table 126. Mayo Clinic Laboratories Description and Business Overview
Table 127. Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Product
Table 128. Mayo Clinic Laboratories Revenue in COVID-19 Molecular Diagnostics Business 2022 & 2028
Table 129. Mayo Clinic Laboratories Recent Development
Table 130. Chembio Diagnostics Company Details
Table 131. Chembio Diagnostics Description and Business Overview
Table 132. Chembio Diagnostics COVID-19 Molecular Diagnostics Product
Table 133. Chembio Diagnostics Revenue in COVID-19 Molecular Diagnostics Business 2022 & 2028
Table 134. Chembio Diagnostics Recent Development
Table 135. Mount Sinai Laboratory Company Details
Table 136. Mount Sinai Laboratory Description and Business Overview
Table 137. Mount Sinai Laboratory COVID-19 Molecular Diagnostics Product
Table 138. Mount Sinai Laboratory Revenue in COVID-19 Molecular Diagnostics Business 2022 & 2028
Table 139. Mount Sinai Laboratory Recent Development
Table 140. QIAGEN Company Details
Table 141. QIAGEN Description and Business Overview
Table 142. QIAGEN COVID-19 Molecular Diagnostics Product
Table 143. QIAGEN Revenue in COVID-19 Molecular Diagnostics Business 2022 & 2028
Table 144. QIAGEN Recent Development
Table 145. Bioer Company Details
Table 146. Bioer Description and Business Overview
Table 147. Bioer COVID-19 Molecular Diagnostics Product
Table 148. Bioer Revenue in COVID-19 Molecular Diagnostics Business 2022 & 2028
Table 149. Bioer Recent Development
Table 150. Biosynex Company Details
Table 151. Biosynex Description and Business Overview
Table 152. Biosynex COVID-19 Molecular Diagnostics Product
Table 153. Biosynex Revenue in COVID-19 Molecular Diagnostics Business 2022 & 2028
Table 154. Biosynex Recent Development
Table 155. Esco Company Details
Table 156. Esco Description and Business Overview
Table 157. Esco COVID-19 Molecular DiagnosticsProduct
Table 158. Esco Revenue in COVID-19 Molecular Diagnostics Business 2022 & 2028
Table 159. Esco Recent Development
Table 160. Analytik Jena Company Details
Table 161. Analytik Jena Description and Business Overview
Table 162. Analytik Jena COVID-19 Molecular Diagnostics Product
Table 163. Analytik Jena Revenue in COVID-19 Molecular Diagnostics Business 2022 & 2028
Table 164. Analytik Jena Recent Development
Table 165. Techne Company Details
Table 166. Techne Description and Business Overview
Table 167. Techne COVID-19 Molecular Diagnostics Product
Table 168. Techne Revenue in COVID-19 Molecular Diagnostics Business 2022 & 2028
Table 169. Techne Recent Development
Table 170. Da An Gene Company Details
Table 171. Da An Gene Description and Business Overview
Table 172. Da An Gene COVID-19 Molecular Diagnostics Product
Table 173. Da An Gene Revenue in COVID-19 Molecular Diagnostics Business 2022 & 2028
Table 174. Da An Gene Recent Development
Table 175. BGI Company Details
Table 176. BGI Description and Business Overview
Table 177. BGI COVID-19 Molecular Diagnostics Product
Table 178. BGI Revenue in COVID-19 Molecular Diagnostics Business 2022 & 2028
Table 179. BGI Recent Development
Table 180. Shanghai ZJ Bio-Tech Company Details
Table 181. Shanghai ZJ Bio-Tech Description and Business Overview
Table 182. Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Product
Table 183. Shanghai ZJ Bio-Tech Revenue in COVID-19 Molecular Diagnostics Business 2022 & 2028
Table 184. Shanghai ZJ Bio-Tech Recent Development
Table 185. COVID-19 Molecular Diagnostics Market Trends
Table 186. COVID-19 Molecular Diagnostics Market Drivers
Table 187. COVID-19 Molecular Diagnostics Market Challenges
Table 188. COVID-19 Molecular Diagnostics Market Restraints
Table 189. Research Programs/Design for This Report
Table 190. Key Data Information from Secondary Sources
Table 191. Key Data Information from Primary Sources
List of Figures
Figure 1. Global COVID-19 Molecular Diagnostics Market Share by Type in 2022 & 2028
Figure 2. High-throughput Sequencing Features
Figure 3. Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR Features
Figure 4. Immunological Detection Features
Figure 5. Global COVID-19 Molecular Diagnostics Market Share by Application in 2022 & 2028
Figure 6. Hospitals Case Studies
Figure 7. Scientific Research Case Studies
Figure 8. Biodiagnostics Case Studies
Figure 9. COVID-19 Molecular Diagnostics Report Years Considered
Figure 10. Global COVID-19 Molecular Diagnostics Market Size and Growth Rate (2022-2028) (US$ Million)
Figure 11. Global COVID-19 Molecular Diagnostics Market Share by Regions (2022-2028)
Figure 12. Global COVID-19 Molecular Diagnostics Market Share by Players in 2021
Figure 13. Global COVID-19 Molecular Diagnostics Market Size Market Share by Type (2022-2028)
Figure 14. Global COVID-19 Molecular Diagnostics Market Size Market Share by Application (2022-2028)
Figure 15. Global COVID-19 Molecular Diagnostics Revenue Market Share by Application in 2021
Figure 16. North America COVID-19 Molecular Diagnostics Market Size 2022-2028 (US$ Million)
Figure 17. Europe COVID-19 Molecular Diagnostics Market Size 2022-2028 (US$ Million)
Figure 18. Asia-Pacific COVID-19 Molecular Diagnostics Market Size 2022-2028 (US$ Million)
Figure 19. COVID-19 Molecular Diagnostics Market Size in Latin America (2022-2028) (US$ Million)
Figure 20. COVID-19 Molecular Diagnostics Market Size in Middle East & Africa (2022-2028) (US$ Million)
Figure 21. Bottom-up and Top-down Approaches for This Report
Figure 22. Data Triangulation
Figure 23. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount